Abstract
This week’s articles describe a new drug conjugate to treat pain, a target for preventing cognitive decline in Alzheimer’s disease, and a strategy for sensitizing RAS-mutant cancers to PARP inhibitors.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
